Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:47 AM EDT

Mosaic ImmunoEngineering (CPMV) Short term Debt (2024 - 2026)

Updated

Mosaic ImmunoEngineering's Short term Debt was $200,000 in Q1 2026, unchanged from $200,000 a year earlier and unchanged from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Short term Debt (2024 - 2026) Analysis & Trends

From Q2 2024 onward, Mosaic ImmunoEngineering has reported Short term Debt for 8 quarters.

  • In earlier years, Short term Debt was $200,000 in FY2024.
  • Compared with a year earlier, Short term Debt was higher in two of the last four quarters, with growth averaging 106.7%.
  • Per Business Quant data, CPMV's Short term Debt in the three quarters before Q1 2026 was $200,000 (Q4 2025), $200,000 (Q3 2025) and $200,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Mosaic ImmunoEngineering 441,423.27 352,385.27 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 73,950.00
Jun 30, 2024 56,133.00
API Access

Mosaic ImmunoEngineering Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=CPMV&period=max&api_key=YOUR_API_KEY